A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Clinical trial NCT00703118 · COMPLETED

Trial details

NCT number: NCT00703118
Sponsor: Tibotec BVBA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2008-10-01
Primary completion: 2010-07-01
Enrollment: 663

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.